Press Releases

June 27, 2006

Takeda Pharmaceutical Company Limited

Osaka, Japan, June 27, 2006 --- Takeda Pharmaceutical Company Limited ("Takeda") today announced that it will establish a new company for European sales & marketing, ("The New Company") in London, UK. The establishment of The New Company is a part of initiatives for solidifying marketing structure in three regions (Japan, USA, Europe) and for conducting self-sustaining and appropriate operations for respective markets. That is one of the management tasks set forth in Takeda's 2006-2010 Medium-Term Management Plan.

The New Company will supervise the overall business activities of Takeda's sales and marketing subsidiaries in Europe(*). Through promoting pan-European strategies from mid-and long-term perspectives, The New Company will enhance the sales and marketing functions of each subsidiary in the region. This approach will support the solid business structures in Europe toward the further growth of Takeda's business in the region.

(*) Laboratoires Takeda (France), Takeda UK Limited (UK),

Takeda Italia Farmaceutici S.p.A. (Italy), Takeda Pharma GmbH (Germany),

Takeda Pharma Ges.m.b.H (Austria), Takeda Pharma AG (Switzerland)

Company name	:	To be determined
Location	:	London, United Kingdom
Capital	:	Sterling pound 4 million
Date of establishment	:	July 2006 (plan)
Start of operation	:	October 2006 (plan)

# # #